← SynDRA
XL388
SynDRA canonical compound SYN1970756 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MTOR |
| Mechanism of action | mTOR inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- XL 388
- (7-(6-aminopyridin-3-yl)-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)(3-fluoro-2-methyl-4-(methylsulfonyl)phenyl)methanone
- B7I5G3Z7XR
- [7-(6-aminopyridin-3-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-(3-fluoro-2-methyl-4-methylsulfonylphenyl)methanone
- CHEMBL2333365
- (7-(6-Amino-3-pyridinyl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)(3-fluoro-2-methyl-4-(methylsulfonyl)phenyl)methanone
- (7-(6-Aminopyridin-3-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl)-(3-fluoro-2-methyl-4-methylsulfonylphenyl)methanone
- [7-(6-Amino-3-pyridinyl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl][3-fluoro-2-methyl-4-(methylsulfonyl)phenyl]-methanone
- Methanone, (7-(6-amino-3-pyridinyl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)(3-fluoro-2-methyl-4-(methylsulfonyl)phenyl)-
- UNII-B7I5G3Z7XR
- GTPL7973
- SCHEMBL3761352
- DTXSID901336669
- BCP07897
- EX-A1571
- BDBM50429867
- s7035
- ZINC95550928
- AKOS024458404
- CCG-269288
- CS-1535
- SB16471
- NCGC00351483-07
- NCGC00351483-09
- AC-31526
- AS-16320
- DA-46704
- HY-13806
- FT-0738721
- A12395
- C71989
- A890275
- J-005199
- Q27089249
- [7-(6-Aminopyridin-3-yl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl][3-fluoro-2-methyl-4-(methylsulfonyl)phenyl]methanone
Look up XL388 in the interactive SynDRA portal →